1. Home
  2. ASRT vs DLHC Comparison

ASRT vs DLHC Comparison

Compare ASRT & DLHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • DLHC
  • Stock Information
  • Founded
  • ASRT 1995
  • DLHC 1969
  • Country
  • ASRT United States
  • DLHC United States
  • Employees
  • ASRT N/A
  • DLHC N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • DLHC Business Services
  • Sector
  • ASRT Health Care
  • DLHC Consumer Discretionary
  • Exchange
  • ASRT Nasdaq
  • DLHC Nasdaq
  • Market Cap
  • ASRT 57.9M
  • DLHC 59.7M
  • IPO Year
  • ASRT 1997
  • DLHC N/A
  • Fundamental
  • Price
  • ASRT $0.66
  • DLHC $5.00
  • Analyst Decision
  • ASRT Strong Buy
  • DLHC
  • Analyst Count
  • ASRT 3
  • DLHC 0
  • Target Price
  • ASRT $3.08
  • DLHC N/A
  • AVG Volume (30 Days)
  • ASRT 284.6K
  • DLHC 48.1K
  • Earning Date
  • ASRT 05-12-2025
  • DLHC 05-07-2025
  • Dividend Yield
  • ASRT N/A
  • DLHC N/A
  • EPS Growth
  • ASRT N/A
  • DLHC 75.08
  • EPS
  • ASRT N/A
  • DLHC 0.38
  • Revenue
  • ASRT $119,001,000.00
  • DLHC $377,074,000.00
  • Revenue This Year
  • ASRT N/A
  • DLHC N/A
  • Revenue Next Year
  • ASRT $11.71
  • DLHC N/A
  • P/E Ratio
  • ASRT N/A
  • DLHC $13.32
  • Revenue Growth
  • ASRT N/A
  • DLHC N/A
  • 52 Week Low
  • ASRT $0.51
  • DLHC $2.72
  • 52 Week High
  • ASRT $1.80
  • DLHC $12.23
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 50.57
  • DLHC 65.31
  • Support Level
  • ASRT $0.67
  • DLHC $4.95
  • Resistance Level
  • ASRT $0.71
  • DLHC $5.13
  • Average True Range (ATR)
  • ASRT 0.04
  • DLHC 0.23
  • MACD
  • ASRT 0.00
  • DLHC 0.02
  • Stochastic Oscillator
  • ASRT 52.69
  • DLHC 81.44

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About DLHC DLH Holdings Corp.

DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.

Share on Social Networks: